Stefanie Krassnig
Overview
Explore the profile of Stefanie Krassnig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krassnig S, Leber S, Orthmann A, Golob-Schwarzl N, Huber H, Wohlrab C, et al.
J Neurooncol
. 2023 Nov;
165(1):91-100.
PMID: 37907716
Purpose: Since glioma therapy is currently still limited until today, new treatment options for this heterogeneous group of tumours are of great interest. Eukaryotic initiation factors (eIFs) are altered in...
2.
Alcaniz J, Winkler L, Dahlmann M, Becker M, Orthmann A, Haybaeck J, et al.
Front Oncol
. 2023 Apr;
13:1129627.
PMID: 37114125
Glioblastoma (GBM) heterogeneity, aggressiveness and infiltrative growth drastically limit success of current standard of care drugs and efficacy of various new therapeutic approaches. There is a need for new therapies...
3.
Golob-Schwarzl N, Schweiger C, Koller C, Krassnig S, Gogg-Kamerer M, Gantenbein N, et al.
Oncotarget
. 2023 Feb;
14:83-84.
PMID: 36745526
No abstract available.
4.
Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer A, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33807050
Glioblastoma (GBM) is an utterly devastating cerebral neoplasm and current therapies only marginally improve patients' overall survival (OS). The PI3K/AKT/mTOR pathway participates in gliomagenesis through regulation of cell growth and...
5.
Skofler C, Kleinegger F, Krassnig S, Birkl-Toeglhofer A, Singer G, Till H, et al.
Cells
. 2021 Feb;
10(2).
PMID: 33540613
Neuroblastoma (NB) is the most common extracranial pediatric solid tumor. Children suffering from high-risk and/or metastatic NB often show no response to therapy, and new therapeutic approaches are urgently needed....
6.
Wernitznig S, Reichmann F, Sele M, Birkl C, Hayback J, Kleinegger F, et al.
J Vis Exp
. 2019 Apr;
(146).
PMID: 31033944
Investigations of the ultrastructural features of neurons and their synapses are only possible with electron microscopy. Especially for comparative studies of the changes in densities and distributions of such features,...
7.
Schatz O, Zalaudek I, Tabrizi-Wizsy N, Grechenig C, Grinninger P, Haas A, et al.
Cells Tissues Organs
. 2019 Jan;
206(1-2):6-8.
PMID: 30654373
No abstract available.
8.
Golob-Schwarzl N, Bettermann K, Mehta A, Kessler S, Unterluggauer J, Krassnig S, et al.
Transl Oncol
. 2018 Nov;
12(2):256-268.
PMID: 30439626
Background & Aims: Steatohepatitis (SH) and SH-associated hepatocellular carcinoma (HCC) are of considerable clinical significance. SH is morphologically characterized by steatosis, liver cell ballooning, cytoplasmic aggregates termed Mallory-Denk bodies (MDBs),...
9.
Kleinegger F, Hofer E, Wodlej C, Golob-Schwarzl N, Birkl-Toeglhofer A, Stallinger A, et al.
Biochim Biophys Acta Mol Basis Dis
. 2018 Nov;
1865(2):308-321.
PMID: 30419338
Biliary tract cancer (BTC) represents a malignant tumor of the biliary tract including cholangiocarcinoma (CCA) and the carcinoma of the gallbladder (GBC) with a 5-year survival rate between 5 and...
10.
Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning K, et al.
Nat Med
. 2018 Aug;
24(10):1611-1624.
PMID: 30150718
Glioblastoma is characterized by widespread genetic and transcriptional heterogeneity, yet little is known about the role of the epigenome in glioblastoma disease progression. Here, we present genome-scale maps of DNA...